Zentiva profited in Türkiye

Reuters - Zentiva has stated that their unit, which includes 75% of the Eczacibasi Pharmaceuticals equivalent pharmaceuticals division acquired last year, has contributed an amount of 1.4 billion Czech Crones to the 1st quarter revenue.